Editorial
doi: 10.1152/ajpcell.00419.2012.
Epub 2013 Jan 30.
Cyclic AMP-mediated pleiotropic effects of glucagon-like peptide-1 receptor activation. Focus on "Exendin-4 attenuates high glucose-induced cardiomyocyte apoptosis via inhibition of endoplasmic reticulum stress and activation of SERCA2a"
- PMID: 23364263
- DOI: 10.1152/ajpcell.00419.2012
Item in Clipboard
Editorial
Cyclic AMP-mediated pleiotropic effects of glucagon-like peptide-1 receptor activation. Focus on "Exendin-4 attenuates high glucose-induced cardiomyocyte apoptosis via inhibition of endoplasmic reticulum stress and activation of SERCA2a"
Am J Physiol Cell Physiol.
2013 Mar.
Free article
No abstract available
Comment on
-
Exendin-4 attenuates high glucose-induced cardiomyocyte apoptosis via inhibition of endoplasmic reticulum stress and activation of SERCA2a.Am J Physiol Cell Physiol. 2013 Mar;304(6):C508-18. doi: 10.1152/ajpcell.00248.2012. Epub 2013 Jan 9. Am J Physiol Cell Physiol. 2013. PMID: 23302777
Similar articles
-
Exendin-4 attenuates high glucose-induced cardiomyocyte apoptosis via inhibition of endoplasmic reticulum stress and activation of SERCA2a.Am J Physiol Cell Physiol. 2013 Mar;304(6):C508-18. doi: 10.1152/ajpcell.00248.2012. Epub 2013 Jan 9. Am J Physiol Cell Physiol. 2013. PMID: 23302777
-
Exendin-4 attenuates endoplasmic reticulum stress through a SIRT1-dependent mechanism.Cell Stress Chaperones. 2014 Sep;19(5):649-56. doi: 10.1007/s12192-013-0490-3. Epub 2014 Jan 21. Cell Stress Chaperones. 2014. PMID: 24446069 Free PMC article.
-
Exendin-4, a glucagon-like peptide-1 receptor agonist, inhibits cell apoptosis induced by lipotoxicity in pancreatic β-cell line.Peptides. 2012 Sep;37(1):18-24. doi: 10.1016/j.peptides.2012.06.018. Epub 2012 Jul 7. Peptides. 2012. PMID: 22776329
-
Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes.Regul Pept. 2004 Feb 15;117(2):77-88. doi: 10.1016/j.regpep.2003.10.028. Regul Pept. 2004. PMID: 14700743 Review.
-
Is exenatide advancing the treatment of type 2 diabetes?Expert Opin Pharmacother. 2006 Jan;7(1):109-12. doi: 10.1517/14656566.7.1.109. Expert Opin Pharmacother. 2006. PMID: 16370928 Review.
Cited by
-
TGR5 activation ameliorates hyperglycemia-induced cardiac hypertrophy in H9c2 cells.Sci Rep. 2019 Mar 6;9(1):3633. doi: 10.1038/s41598-019-40002-0. Sci Rep. 2019. PMID: 30842472 Free PMC article.
-
Novel fusion of GLP-1 with a domain antibody to serum albumin prolongs protection against myocardial ischemia/reperfusion injury in the rat.Cardiovasc Diabetol. 2013 Oct 14;12:148. doi: 10.1186/1475-2840-12-148. Cardiovasc Diabetol. 2013. PMID: 24125539 Free PMC article.
-
Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels.Transl Psychiatry. 2016 May 17;6(5):e809. doi: 10.1038/tp.2016.86. Transl Psychiatry. 2016. PMID: 27187231 Free PMC article.
-
Amelioration of muscle wasting by glucagon-like peptide-1 receptor agonist in muscle atrophy.J Cachexia Sarcopenia Muscle. 2019 Aug;10(4):903-918. doi: 10.1002/jcsm.12434. Epub 2019 Apr 24. J Cachexia Sarcopenia Muscle. 2019. PMID: 31020810 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
